Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("RIZZIERI, David A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

Alemtuzumab for the prevention and treatment of graft-versus-host disease : PIH: Role of monoclonal antibodies for the prevention and treatment of graft-versus-host diseaseKANDA, Junya; LOPEZ, Richard D; RIZZIERI, David A et al.International journal of hematology. 2011, Vol 93, Num 5, pp 586-593, issn 0925-5710, 8 p.Article

Monoclonal antibody therapy in the treatment of non-Hodgkin lymphomaMCCUNE, Steven L; GOCKERMAN, Jon P; RIZZIERI, David A et al.JAMA, the journal of the American Medical Association. 2001, Vol 286, Num 10, pp 1149-1152, issn 0098-7484Article

Pulmonary sarcoidosis following stem cell transplantation: Is it more than a chance occurrence?BHAGAT, Rajesh; RIZZIERI, David A; VREDENBURGH, James J et al.Chest. 2004, Vol 126, Num 2, pp 642-644, issn 0012-3692, 3 p.Article

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphomaBASS, Adam J; GOCKERMAN, Jon P; RIZZIERI, David A et al.Journal of clinical oncology. 2002, Vol 20, Num 13, pp 2995-3000, issn 0732-183XArticle

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemiaRIZZIERI, David A; BASS, Adam J; JACOBSON, Robert et al.Journal of clinical oncology. 2002, Vol 20, Num 3, pp 674-679, issn 0732-183XArticle

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimenRIZZIERI, David A; LONG, Gwynn D; VREDENBURGH, James J et al.Blood. 2001, Vol 98, Num 12, pp 3486-3488, issn 0006-4971Article

The genetic landscape of mutations in Burkitt lymphomaLOVE, Cassandra; ZHEN SUN; LUGAR, Patricia L et al.Nature genetics. 2012, Vol 44, Num 12, pp 1321-1325, issn 1061-4036, 5 p.Article

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemiaLEE, Stephanie J; KUKREJA, Manisha; HALTER, Joerg et al.Blood. 2008, Vol 112, Num 8, pp 3500-3507, issn 0006-4971, 8 p.Article

Phase I evaluation of Prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemiaRIZZIERI, David A; IBOM, Valerie K; GASPARETTO, Christina et al.Clinical cancer research. 2003, Vol 9, Num 2, pp 663-668, issn 1078-0432, 6 p.Article

Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cellsGUZMAN, Monica L; NEERING, Sarah J; UPCHURCH, Donna et al.Blood. 2001, Vol 98, Num 8, pp 2301-2307, issn 0006-4971Article

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remissionMARKS, David I; TAO WANG; KLUMPP, Thomas R et al.Blood. 2010, Vol 116, Num 3, pp 366-374, issn 0006-4971, 9 p.Article

Patterns of microRNA expression characterize stages of human B-cell differentiationZHANG, Jenny; JIMA, Dereje D; WEINBERG, J. Brice et al.Blood. 2009, Vol 113, Num 19, pp 4586-4594, issn 0006-4971, 9 p.Article

Partially matched, nonmyeloablative allogeneic transplantation : Clinical outcomes and immune reconstitutionRIZZIERI, David A; LIANG PIU KOH; NIEDZWIECKI, Donna et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 690-697, issn 0732-183X, 8 p.Article

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantationSNYDER, Matthew J; STENZEL, Timothy T; BUCKLEY, Patrick J et al.The American journal of surgical pathology. 2004, Vol 28, Num 6, pp 794-800, issn 0147-5185, 7 p.Article

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphomaRIZZIERI, David A; AKABANI, Gamal; PEGRAM, Charles N et al.Blood. 2004, Vol 104, Num 3, pp 642-648, issn 0006-4971, 7 p.Article

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donorsLAUGHLIN, Mary J; BARKER, Juliet; RUBINSTEIN, Pablo et al.The New England journal of medicine. 2001, Vol 344, Num 24, pp 1815-1822, issn 0028-4793Article

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and ModalityFENSKE, Timothy S; ZHANG, Mei-Jie; HOLMBERG, Leona A et al.Journal of clinical oncology. 2014, Vol 32, Num 4, pp 273-281, issn 0732-183X, 9 p.Article

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002RIZZIERI, David A; JOHNSON, Jeffrey L; LARSON, Richard A et al.British journal of haematology. 2014, Vol 165, Num 1, pp 102-111, issn 0007-1048, 10 p.Article

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction FailureDUVAL, Michel; KLEIN, John P; KEATING, Armand et al.Journal of clinical oncology. 2010, Vol 28, Num 23, pp 3730-3738, issn 0732-183X, 9 p.Article

Outcomes of Patients Who Undergo Aggressive Induction Therapy for Secondary Acute Myeloid LeukemiaRIZZIERI, David A; O'BRIEN, Jenny A; MOORE, Joseph O et al.Cancer. 2009, Vol 115, Num 13, pp 2922-2929, issn 0008-543X, 8 p.Article

Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemiaSHANKS, Ryan H; RIZZIERI, David A; FLOWERS, James L et al.Clinical cancer research. 2005, Vol 11, Num 11, pp 4225-4233, issn 1078-0432, 9 p.Article

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: Final results of cancer and leukemia group B study 9251RIZZIERI, David A; JOHNSON, Jeffrey L; CANELLOS, George P et al.Cancer. 2004, Vol 100, Num 7, pp 1438-1448, issn 0008-543X, 11 p.Article

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvementMAZIARZ, Richard T; ZHIWEI WANG; HOLMBERG, Leona et al.British journal of haematology. 2013, Vol 162, Num 5, pp 648-656, issn 0007-1048, 9 p.Article

SEVERE PULMONARY TOXICITY AFTER MYELOABLATIVE CONDITIONING USING TOTAL BODY IRRADIATION: AN ASSESSMENT OF RISK FACTORSKELSEY, Chris R; HORWITZ, Mitchell E; CHINO, Junzo P et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 3, pp 812-818, issn 0360-3016, 7 p.Article

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphomaRIZZIERI, David A; SAND, Gregory J; FOSTER, Tracy et al.Cancer. 2004, Vol 100, Num 11, pp 2408-2414, issn 0008-543X, 7 p.Article

  • Page / 2